Committed Capital
By Dechert LLP
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Dechert LLP
Category: Business
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 5
Reviews: 0
Episodes: 43
Description
With private equity firms sitting on record levels of dry powder, opportunities for PE investment and dealmaking still abound. Yet complexities surrounding valuation, due diligence and financing are at an all-time high. Hosted by members of Dechert’s Private Equity practice, Committed Capital explores current issues and trends affecting PE globally, featuring conversations with leaders from across the industry.
© 2025 Dechert LLP. All rights reserved. This information should not be considered as legal opinions on specific facts or as a substitute for legal counsel. It is provided by Dechert LLP as a general informational service and may be considered attorney advertising in some jurisdictions.
| Episode | Date |
|---|---|
|
PE Rx: Navigating Oregon’s New Healthcare Rules and the Evolving State Law Landscape
|
Sep 04, 2025 |
|
Sidecar: New Order ‘Targets’ 401(k) Plan ‘Alternatives’
|
Aug 20, 2025 |
|
2025 Global Private Equity Outlook: Key Legal Developments and Trends to Watch
|
Mar 18, 2025 |
|
Sidecar: A New Dawn for HSR – What the FTC’s New Premerger Notification Requirements Mean for Private Equity
|
Feb 19, 2025 |
|
Unlocking Value: GP-Stake Sales and Seeding Transactions
|
Nov 26, 2024 |
|
Taking Stock: Industry Leaders Discuss Private Equity’s Evolution and Future to Mark Dechert’s 40th Anniversary in PE
|
Oct 30, 2024 |
|
Sidecar: The New EU FSR’s Impact on Private Equity Transactions
|
Sep 26, 2024 |
|
Sidecar: CFIUS, Springing Rights and the Equity Stack
|
Aug 27, 2024 |
|
The Evolving Credit Secondaries Market
|
Mar 11, 2024 |
|
2024 Global Private Equity Outlook: Trends and Opportunities
|
Jan 17, 2024 |
|
Private Equity Investments in Food and Agriculture
|
Nov 02, 2023 |
|
Sidecar: The Corporate Transparency Act - Implementation Update
|
Sep 11, 2023 |
|
Sidecar: FTC Proposes Substantial Changes to HSR Filings – How Will It Affect Private Equity?
|
Aug 23, 2023 |
|
Sidecar: The New U.S. Outbound Investment Regime and Considerations for Private Equity
|
Aug 15, 2023 |
|
Private Credit: State of the Market
|
Aug 09, 2023 |
|
Private Equity Financings: Market Trends and Conditions
|
Apr 28, 2023 |
|
The Current Environment for Workouts and Restructurings
|
Mar 22, 2023 |
|
DOJ’s Stepped-Up Enforcement Against Interlocking Directorates
|
Feb 07, 2023 |
|
2023 Global Private Equity Outlook: Industry Resilience
|
Jan 24, 2023 |
|
The Retailization of Private Equity in Europe: A Growing Phenomenon
|
Oct 31, 2022 |
|
Healthcare M&A: State of the Market and Future Trends Explored
|
Oct 06, 2022 |
|
European PE Funds Expanding into the U.S. – A New Trend in Globalization?
|
Jul 07, 2022 |
|
Sidecar: Delaware, Sandbagging and PE Transactions
|
Apr 08, 2022 |
|
Sidecar: Hot Documents in Merger Review
|
Mar 29, 2022 |
|
Private Equity Investment in the Financial Services Sector
|
Mar 18, 2022 |
|
Private Equity Secondary Transactions – Continuation Funds
|
Feb 25, 2022 |
|
2022 Global Private Equity Outlook: Record Deal Volumes, Private Credit, Growth Equity, Secondaries, SPACs, ESG and Sector Highlights
|
Jan 24, 2022 |
|
Sidecar: FTC’s New Prior Approval Policy – Impact on Risks and Deal Terms
|
Dec 10, 2021 |
|
Trends in Equity Co-Investments
|
Sep 15, 2021 |
|
Sidecar: Increased Foreign Direct Investment Scrutiny – How Are PE Firms Impacted?
|
Aug 16, 2021 |
|
Sidecar: Rep and Warranty Insurance – Latest Trends and Developments
|
Jul 26, 2021 |
|
First 100 Days: Legal Pitfalls and Opportunities for New PE Funds
|
Jul 01, 2021 |
|
Secondaries: Dry Powder and Paradigm Shifts
|
May 27, 2021 |
|
Sidecar: PREP Act Liability Immunity – Considerations for PE Portfolio Companies During COVID-19
|
May 17, 2021 |
|
ESG and Asset Management: Challenges and Opportunities
|
Apr 25, 2021 |
|
Sidecar: FTC Suspends HSR Early Termination – How Will It Impact Deal Timing?
|
Mar 16, 2021 |
|
Managing Cybersecurity Risk in Private Equity Transactions: Investing in the Modern Age
|
Feb 22, 2021 |
|
Sidecar: The Corporate Transparency Act – Will My Business Be Affected?
|
Feb 17, 2021 |
|
A Strong Recovery? PE Life Sciences and Healthcare Investment Opportunities in 2021
|
Jan 26, 2021 |
|
SPACs, Election Impact and Industry Resilience: 2021 Global Private Equity Outlook
|
Dec 15, 2020 |
|
The Market for Private Equity Financing
|
Oct 14, 2020 |
|
Getting Deals Done in the Current Environment
|
Sep 01, 2020 |
|
Private Equity Outlook for 2020: Current Trends and Moving Forward
|
Aug 06, 2020 |